UCSF 15th International Conference Neonatal & Childhood Pulmonary Vascular Disease 2022

• Include: 6 videos + 38 pdfs, size: 17.1 GB
• Target Audience: Pediatric and Adult Pulmonologists, Cardiology and Critical Care Physicians, Neonatology Physicians

 Information:

Overview:

UCSF 15th International Conference Neonatal & Childhood Pulmonary Vascular Disease 2022 Over the past decade, great strides have been made in our understanding of the pathobiology of pulmonary vascular disease, and from these findings new therapeutic options have emerged. It is increasingly clear that pulmonary vascular pathology is integral to a number of childhood disorders. In this symposium, we will bring together international experts to explore our current understanding of the basic pathobiology as well as new and future therapies for neonatal, pediatric, and adult pulmonary vascular diseases.

Target Audience Pediatric and Adult Pulmonologists, Cardiology and Critical Care Physicians, Neonatology Physicians, and Advanced Practice Nurses.

Objectives:

• Apply new knowledge of the developmental vascular biology of neonatal pulmonary vascular disease to increase early detection of the pathology in infants;
• Provide strategies for multi-disciplinary teams to optimize the role of nursing in the care of neonates, infants, and children with pulmonary vascular disease;
• Assess current and future therapeutic strategies;
• Understand the impact of pulmonary vascular disease in middle-to-low income regions ;
• Understand the rapidly expanding understanding of the genetics and genomics of pulmonary vascular disease;
• Updates on the latest basic and clinical science breakthroughs related to pulmonary vascular disease;
• Mentoring and career advice for trainees and junior faculty interested in Pediatric Pulmonary Vascular Disease.

UCSF 15th International Conference Neonatal & Childhood Pulmonary Vascular Disease 2022

 Topics:

*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below

• 001_MPD22002_Syllabus_Intro.pdf
• 01_BRUNEAU_Development_RV.pdf
• 01_FRI_PEYVANDI_Pulmonary_Vasculature .pdf
• 02_LEVY_Right Ventricular.pdf
• 02_REDINGTON_RV_Response.pdf
• 03_THURS_FREIDBERG_RV_Function.pdf
• 03_ZANI_Novel_Approaches.pdf
• 04_FRI_LAKSHMINRUSIMHA_Pre-term_Newborn.pdf
• 04_MOLEDINA_UCSF.pdf
• 05_Single_Cell.pdf
• 05_THURS_ROSS_Pulmonary_Embolism.pdf
• 06b_FRI_HUMBERT_Robyn Barst.pdf
• 06_KELLER_Ductal_Patency.pdf
• 07_AMIN_Transcatheter_Therapy.pdf
• 07_FAIRCLOTH_Pharmacotherapy.pdf
• 08_FRI_ARCHER_SARS-CoV-2_Mitochondriopathy .pdf
• 08_THURS_COLEMAN_RVF_Survey.pdf
• 10_THUR_CAPLAN_Failing_RV.pdf
• 11_a_THURS_COULSON_RV_Failure.pdf
• 11_b_Mechanical_and_Surgical_Support.pdf
• 11_ROSENZWEIG_COVID_in_Peds.pdf
• 11_THURS_EGHTESADY_Failing_RV.pdf
• 12_LEONARD_Wellbeing.pdf
• 13_WHETSTONE_Contraception_AUB.pdf
• 14_KELLY_Adolescent_Mental_Health.pdf
• 19_Registry_Update.pdf
• 2022-02-16_MPD22002_Feb_25-26_General_Session.pdf
• 20_KRISHNAN_PVS_Medical_Therapy.pdf
• 21_HIRSCH_2022 Update.pdf
• 22_SAT_CALDERONE_Surgical_Update.pdf
• 23_Review_Basic_Science_Literature.pdf
• 24_Ivy_UCSF.DDI.pdf
• 25_BHernan_PH_Presentation.pdf
• 25_b_Cruz-Utrilla_SFO2.pdf
• 25_c_Ivy. Actigraphy.pdf
• 26_ROSENZWEIG_PVDOMICS.pdf
• 28_SAT_EVERETT_Pediatric_Survial.pdf
• 31_a_GRIFFITHS_PHUZZLERS.pdf
• February 24 AM Session.mp4 (3 hours 40 minutes)
• February 24 PM Session.mp4 (3 hours)
• February 25 AM Session.mp4 (4 hours)
• February 25 PM Session.mp4 (6 hours)
• February 26 AM Session.mp4 (3 hours)
• February 26 PM Session.mp4 (4 hours)

*Detail:

Thursday, February 24, 2022

7:30am PT Registration and Coffee
7:50 Welcome and Introduction Drs. Ryan Coleman and Lew Romer

• SESSION 1: DEVELOPMENT AND ASSESSMENT OF THE RIGHT VENTRICLE Moderators: Drs. Maria Del Cerro and Hythem Nawaytou
  8:00 1. Development of the Right Ventricle Dr. Benoit Bruneau
  8:30 2. The RV Response to Acute and Chronic Increases in Afterload Dr. Andrew Redington
  9:00 3. Assessment of RV Function: The Role of Echocardiography Dr. Mark Friedberg
  9:30 4. Assessment of RV Function: The Role of MRI/CT Dr. Shahin Moledina
  10:00 5. Acute Pulmonary Embolism: Diagnosis and Treatment (Recorded) Dr. Catherine Ross
  10:30 Moderated Q&A
  11:00 Break
• SESSION 2: MANAGEMENT OF THE FAILING RIGHT VENTRICLE – PART I Moderators: Drs. Corey Chartan and Vamsi Yarlagadda
  11:15 6. Maintaining Ductal Patency in Neonatal RV Dysfunction Dr. Roberta Keller
  11:45 7. Catheter-Based Interventions for the Failing RV Dr. Elena Amin
  12:15 Moderated Q & A
  1:00 pm PT Lunch on Your Own
• SESSION 3: MANAGEMENT OF THE FAILING RIGHT VENTRICLE – PART II Moderators: Drs. Ryan Coleman and Satish Rajagopal
  2:30 8. ICU Management: A Spectrum of Approaches (Report of an InternationalSurvey) Dr. Ryan Coleman
  2:45 9. Approaching the Failing RV: The Cardiac Intensivist’s Perspective Dr. Mjaye Mazwi
  3:15 10. Approaching the Failing RV: The Anesthesiologist’s Perspective Dr. Lisa Caplan
  3:45 11. Mechanical and Surgical Support for the Failing RV Drs. Pirooz Eghtesady and Mark Grady
  4:45 Moderated Q&A
  5:15 Challenging Cases
  5:45 pm PT Closing Remarks and Adjourn

FRIDAY, FEBRUARY 25th, 2022

• 7:00 am Registration and Continental Breakfast
  7:45 Welcome and Opening Remarks
• SESSION 1: NEW MECHANISMS AND POTENTIAL THERAPIES FOR NEONATAL PULMONARY DISEASE MODERATORS: Drs. Roberta Keller and Bernard Thébaud
  8:00 1. Fetal Evaluation of the Pulmonary Vasculature in at Risk Populations Dr. Shabnam Peyvandi
  8:25 2. Right Ventricular–Pulmonary Vascular Interactions in the Neonate and Infant: Role of Standard and Novel Imaging Techniques to Detect Detrimental Changes Dr. Phil Levy
  8:50 3. Novel Approaches to Developmental Lung Diseases of the Pulmonary Vasculature: Antenatal Cell-Based Interventions for CDH Dr. Augusto Zani
  9:15 4. What’s Old is Still Relevant: The Role of Inhaled Nitric Oxide in the Pre-term Newborn Dr. Satyan Lakshminrusimha
  9:40 Break
• SESSION 2: Special Scientific Presentations MODERATORS: Drs. Steven Abman and Lew Romer
  9:55 5. Special Lecture: Leveraging Multi-Omics in Vascular Biology Dr. Cristina Alvira
  10:20 6. The Lucas Van Wormer Best Trainee Research Award Introduction: Dr. Dunbar Ivy Clinical Phenotype and Treatment Strategies in Children with Pulmonary Hypertension And TBX4 Disease Dr. Cara Morgan
  10:55 Introduction: The Robyn Barst Keynote Lecture Dr. Bernard Thébaud
  11:00 KEYNOTE SPEAKER: The Robyn Barst Keynote Lecture (Recorded) Genotype Phenotype Relationships in Heritable Pulmonary Hypertension Dr. Marc Humbert
  12:00-1:15 pm Lunch on Own
• SESSION 3: Pediatric Drug Delivery: A Practical Discussion
  1:15 pm – 2:00 pm MODERATORS: Elizabeth Colglazier and Emma Jackson
  1:15 7. Jenna Faircloth, PharmD, BCPS
• SESSION 4: COVID 19 and the Pulmonary Vasculature: Lessons Learned MODERATORS: Drs. Jason Boehme and Eric Austin
  2:00 8. A SARS-CoV-2 Mitochondriopathy in COVID-19 Pneumonia Dr. Stephen Archer
  2:25 9. COVID: Animal Models and Clinical Trials (Recorded) Dr. Duncan Stewart
  2:50 10. COVID Pulmonary Vasculature Pathology (Recorded) Dr. Csaba Galambos
  3:15 11. COVID in Childhood and PH Patients Dr. Erika Rosenzweig
  3:40 Break
• SESSION 5: Caring for the Adolescent Patient with Pulmonary Hypertension MODERATORS: Claire Parker and Michelle Ogawa
  3:50 12. Using a Strengths-Based Approach to Promote Adolescent Wellbeing Adam Leonard, PNP, MPH
  4:20 13. Management of Abnormal Uterine Bleeding and Contraception Dr. Sara Whetstone
  4:50 14. PH: Mental Health Dr. Sarah Kelly
  5:20 15. Palliative Care and Advanced Directives (Recorded) Dr. Alison Miles
  5:45 16. Pathology Round Table Dr. Csaba Galambos
  6:45 pm Adjourn

SATURDAY, FEBRUARY 26th, 2022

• 6:30 am Continental Breakfast
  7:00 18. Sunrise Discussion: Meet the Mentors: Small Groups Sessions Round Table Topics Include: Clinical PH Training and Starting and Maintaining a Multi-Disciplinary PH Program
• SESSION 5: Pulmonary Vein Stenosis: An Update MODERATORS: Drs. Rachel Vanderlaan and Emily Morell
  8:00 19. PVS Network: General Update Dr. Rachel Vanderlaan
  8:15 20. Medical Therapies: An Update Dr. Usha Krishnan
  8:40 21. Catheter-Based Therapy: An Update Dr. Russel Hirsch
  9:05 22. Surgical Therapies: An Update (Recorded) Dr. Chris Caldarone
  9:30 am Break
• SESSION 6: SCIENTIFIC SESSION INCLUDING ABSTRACT POSTER SYMPOSIUM (10:00 am – 12:30 pm – General Session Room) MODERATORS: Drs. Sanjeev Datar and Bernard Thébaud
  11:00 23. The Year in Review: Basic Science Dr. Usha Raj
  11:30 24. The Year in Review: Clinical Science Dr. Dunbar Ivy
  12:00 pm 25. Platform Sessions: Brief Poster Oral Discussions
  12:30 Boxed Lunch

SESSION 7: PANEL DISCUSSION: The Genotype-Phenotype Approach to the PAH Patient Faculty: Drs. Eric Austin, Wendy Chung, and Erika Rosenzweig
1:15 PVDOMICS Dr. Erika Rosenzweig

SESSION 8: Risk Assessment and Therapeutic Updates MODERATORS: Drs. Maria Del Cerro and Rachel Hopper
2:15 27. Risk Assessment of Pulmonary Arterial Hypertension Dr. Raymond Benza
2:45 28. Risk Assessment: Pediatric Perspectives (Recorded) Dr. Allen Everett
3:15 29. Therapeutic Approach to the Newly Diagnosed Patient: Mono, Duel, or Triple? Dr. Rolf Berger
3:45 30. New and Future Therapies for PAH and RV failure Dr. Paul Yu
4:00 Break
4:15 31. Case Presentations: The PHuzzlers
5:30 pm Closing Remarks and Adjour